People · Operator
Named in public records as an officer, director or promoter · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Transgenrx Inc | — | Biotechnology | Series A | $16.9M | $235.2M | — |
Philippe C Tremml at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philippe C Tremml on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Douglas H. Altschuler | 1 | 1 |
| Victor C. Filatov | 1 | 1 |
| Philipe C. Tremml | 1 | 1 |
| Richard C. Cooper | 1 | 1 |
| Robert J. Kenney | 1 | 1 |
| John C. Gallagher | 1 | 1 |
| William C. Fioretti | 1 | 1 |
| Robert B. Kenney | 1 | 1 |
| John B. Gallagher | 1 | 1 |
| Robert C Kenney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.